From early development to old age, cell death is a part of life. Without enough of a critical type of cell death known as ...

Recent research highlights a method that disrupts the interaction between two key proteins, offering a more precise and ...

The oncology apoptosis modulators market, valued at USD 3.9 billion in 2022, is poised for significant growth, with ...

From early development to old age, cell death is a part of life. Without enough of a critical type of cell death known as ...

Cancer remains one of the leading global causes of mortality, with an estimated increase in cases due to lifestyle, ...

Genprex has entered an exclusive licensing agreement with the University of Michigan for lung cancer therapy, Reqorsa.

Cancer is thought to be the second most prevalent and leading cause of mortality worldwide, affecting both men and women among other chronic diseases. While there are several treatment options ...

Polymorphisms in upstream activators, repressors or downstream effectors of p53 might individually modulate cancer ... transfected cell lines. The biological effects of p53 pathway variants ...

A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 ...

Less is known about the physiological roles of p53 that are not necessarily linked to tumour suppression ... with transfected cell lines. The biological effects of p53 pathway variants at the ...